Use of a high-purity factor VIII concentrate (Hemate P) in von Willebrand's disease

Vox Sanguinis
E Berntorp, I M Nilsson

Abstract

In previous studies, we have found Hemate P (Behring) to be the only commercial virus-inactivated high-purity factor VIII concentrate that contains native von Willebrand factor. In the present study, Hemate P was given to 7 patients with the severe recessive form of von Willebrand's disease, to 2 patients with type Ia, to 1 patient with type IIB, and to 1 patient with type IIC von Willebrand's disease. A correction of the hemostatic defect was seen in all patients. Satisfactory hemostasis was also obtained in clinical situations, 1 patient undergoing major surgery and another being delivered, both without undue loss of blood. We conclude that Hemate P is an efficacious and safe product for use in cases of von Willebrand's disease when pharmacological correction of the hemostatic defect is not possible.

References

Dec 1, 1977·British Journal of Haematology·I M Nilsson, U Hedner
Apr 1, 1978·Thrombosis Research·L Holmberg, R Ljung
Apr 19, 1985·JAMA : the Journal of the American Medical Association·M E EysterW A Blattner
Feb 1, 1985·Scandinavian Journal of Clinical and Laboratory Investigation·S LammeH O Sjögren
Apr 1, 1985·American Journal of Hematology·H Takahashi
Oct 1, 1985·American Journal of Hematology·W T HannaT S Zimmerman
Jan 1, 1974·Thrombosis Research·J A van MourikI A Mochtar
Jan 1, 1984·Scandinavian Journal of Haematology. Supplementum·I M NilssonA C Kristoffersson

❮ Previous
Next ❯

Citations

Feb 24, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·A B Federici, P M Mannucci
Feb 24, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·J M Lusher
Feb 24, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·H J MetznerJ Friedebold
Feb 24, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·A DobrkovskaJ R Chediak
Jan 22, 2005·Seminars in Hematology·Francesco Rodeghiero, Giancarlo Castaman
Mar 7, 2002·Current Opinion in Pediatrics·Augusto B Federici, Pier Mannuccio Mannucci
Jul 5, 2011·Journal of Medical Case Reports·Bijan Keikhaei, Ahmad Soltani Shirazi
Jul 1, 1997·Haemophilia : the Official Journal of the World Federation of Hemophilia
Apr 26, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Augusto B Federici
Sep 30, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Javier BatlleMaría Almudena Pérez-Rodríguez
Feb 14, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·A R ThompsonUNKNOWN Humate-P Study Group
Apr 17, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·K J PasiI R Peake
Nov 7, 2006·Haemophilia : the Official Journal of the World Federation of Hemophilia·A B FedericiC A Lee
Apr 1, 1991·Baillière's Clinical Haematology·V S BlanchetteC Turner
Aug 30, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·A B FedericiUNKNOWN Italian Association of Hemophilia Centers (AICE)
Jun 27, 1998·The British Journal of Oral & Maxillofacial Surgery·J T Wilde, R J Cook
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·A H MinersC A Lee
May 4, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·J C GillM Manco-Johnson
Aug 1, 1993·Critical Reviews in Oncology/hematology·S Lethagen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.